In vivo study demonstrates reduced depressive and anxiety-like behaviors in stressed mice, suggesting bisabolol mitigates neuropsychiatric deficits through antioxidant pathways.
Aim of the study The present study aimed to investigate the antidepressant and anxiolytic effect of (-)-αbisabolol (BIS) and its possible mechanisms of action related to alterations on products of oxidative stress, using the model of depression induced by Chronic Unpredictable Mild Stress Subject or material and methods The male C57BL/6 mice were exposed to CUMS for 28 days, and the depressive and anxious-like behaviors was observed in the animals at the end of the protocol. Results The depressive and anxious behavior was successfully attenuated after BIS administration, evidenced in forced swimming tests and preference for sucrose solution results, with exciting results when compared to Fluoxetine, the reference drug for depression. Discussion The antioxidant profile as mechanism indicated a significant reduction of thiobarbituric acid reactive substances (TBARS) levels in hippocampus area. Conclusions In brief, the study revealed that BIS relieve depressive and anxiety-like state through mitigating oxidative stress.
No takes yet. Share an insight, caveat, or question.
Rebouças et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: